Skip to main content

Table 1 Clinical characteristics of the patients using different ports

From: Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli

Variables All patients Bard TYCO P value
N 552 113 (20 %) 439 (80 %)  
Sex—n (%)     0.0003
 Female 317 (57 %) 48 (42 %) 269 (61 %)  
 Male 235 (43 %) 65 (58 %) 170 (39 %)  
Age—mean ± SD 59.9 ± 12.3 63.6 ± 11 58.9 ± 12.4 0.0002
Age—n (%)     0.0050
 Age ≤ 65 369 (67 %) 63 (56 %) 306 (70 %)  
 Age > 65 183 (33 %) 50 (44 %) 133 (30 %)  
Malignancy (indication for the port)—n (%)     <0.0001
 Lung cancer 105 (19 %) 34 (30 %) 71 (16 %)  
 Head and neck tumor 29 (5 %) 4 (4 %) 25 (6 %)  
 Breast cancer 132 (24 %) 8 (7 %) 124 (28 %)  
 Esophageal cancer 5 (1 %) 0 (0 %) 5 (1 %)  
 Gastric cancer 22 (4 %) 7 (6 %) 15 (3 %)  
 Colorectal cancer 114 (21 %) 28 (25 %) 86 (20 %)  
 Urological cancer 55 (10 %) 14 (12 %) 41 (9 %)  
 Ovary cancer and cervical cancer 47 (9 %) 9 (8 %) 38 (9 %)  
 Hepatobiliary and pancreatic tumor 9 (2 %) 4 (4 %) 5 (1 %)  
 Leukemia and lymphoma 25 (5 %) 3 (3 %) 22 (5 %)  
 Other malignancies 9 (2 %) 2 (2 %) 7 (2 %)  
Malignancy (lung cancer or others)—n (%)     0.0008
 Lung cancer 105 (19 %) 34 (30 %) 71 (16 %)  
 Other malignancies 447 (81 %) 79 (70 %) 368 (84 %)  
Surgeon—n (%)     0.0031
 Surgeon A 142 (26 %) 37 (33 %) 105 (24 %)  
 Surgeon B 358 (65 %) 74 (65 %) 284 (65 %)  
 Other surgeons 52 (9 %) 2 (2 %) 50 (11 %)  
Port infection (+)—n (%) 34 (6 %) 2 (2 %) 32 (7 %) 0.0295
 Gram-positive bacteria 15 (44 %) 2 (100 %) 13 (41 %) 0.1009
S. aureus 13 (38 %) 2 (100 %) 11 (34 %) 0.0639
 Gram-negative bacteria 19 (56 %) 1 (50 %) 18 (56 %) 0.8629
K. pneumoniae 10 (29 %) 0 (0 %) 10 (31 %) 0.3467
Candida spp. 4 (12 %) 0 (0 %) 4 (13 %) 0.5945